News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merrion Pharmaceuticals, Inc. is Issued a Key United States Patent


3/2/2010 8:33:46 AM

DUBLIN, Ireland, March 2, 2010 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals plc (IEX:MERR), an international specialty pharmaceutical company, today announced the issuance of United States Patent No. 7,658,938, "Solid Oral Dosage Form Containing an Enhancer." This patent covers the Company's GIPETĀ® enhancer system used with the bisphosphonate class of drugs. A patent covering the GIPET technology including its use with bisphosphonates has been previously granted in Europe.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES